Complications of intraoperative radiofrequency ablation of liver metastases

BACKGROUND

Intraoperative radiofrequency ablation (IRFA) of liver metastases can be used to treat patients with complex tumours that are unsuitable for parenchymal resection alone. This systematic review assesses the frequency, patterns and severity of complications associated with this procedure.

METHODS

We carried out a bibliographic search on MEDLINE focused on IRFA for liver metastases, excluding hepatocarcinomas, and on intraoperative use, excluding percutaneous application.

RESULTS

Thirty papers published between 1999 and 2007 were analysed. They covered a total of 2822 patients and 1755 IRFA procedures. The indications and techniques for IRFA differ from those for percutaneous treatment, as do associated results and complications. Specific complications associated with IRFA, such as liver abscesses, biliary stenoses and vascular thromboses, are directly correlated with the indications and associated procedures. Published results should be interpreted with caution as IRFA can be used alone or combined with parenchymal resection.

CONCLUSIONS

Specific complications related to IRFA are rare, especially for lesions of <35 mm in size located far from a main biliary duct, when additional septic procedures are not used. A lesion-by-lesion approach based on the benefit : risk ratio should therefore be used in the process of making surgical decisions. Combining resection with IRFA leads to higher morbidity, especially in difficult patients with numerous bilateral lesions, but may be necessary to achieve R0 (microscopically negative margins) outcomes.

[Intraoperative radiofrequency ablation of liver metastases: age of reason]

Intraoperative radiofrequency ablation (IORA) is a surgical technique used to destroy liver metastases by heat. It is performed by a surgeon experienced in intraoperative ultrasounds. It has been officially registered in the French nomenclature of medical acts in 2009. Indications and results of IORA are very different from those of the percutaneous route used by radiologists. Ten years of experience have allowed to define IORA indications in complement to resection which remains the gold standard of liver surgery: 1) lesion no greater than 30 mm in diameter; 2) no proximity to a major portal structure; 3) use of a straight needle with overlapping heat volumes; 4) complete vascular exclusion (portal and sus-hepatic circulation) to treat para-sus-hepatic lesions; 5) requirement to spare parenchymal liver volume. Positive preliminary data of two prospective studies, the EORTCC CLOCC study and the ARF2003 study confirm that IORA complements surgery to obtain complete resection in a larger proportion of patients after chemotherapy induction.